{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:16:38Z","timestamp":1792451798102,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T00:00:00Z","timestamp":1548028800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00330-018-5959-0","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T20:25:09Z","timestamp":1552681509000},"page":"4286-4293","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Integrated analysis of 18F-FDG PET\/CT improves preoperative lymph node staging for patients with invasive bladder cancer"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9472-9980","authenticated-orcid":false,"given":"Antoine","family":"Girard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Rouanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Taconet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cam\u00e9lia","family":"Radulescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Neuzillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Girma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Beaufrere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Lebret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Le Stanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Grellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,21]]},"reference":[{"key":"5959_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87\u2013108","journal-title":"CA Cancer J Clin"},{"key":"5959_CR2","doi-asserted-by":"publisher","first-page":"17022","DOI":"10.1038\/nrdp.2017.22","volume":"3","author":"O Sanli","year":"2017","unstructured":"Sanli O, Dobruch J, Knowles MA et al (2017) Bladder cancer. Nat Rev Dis Primers 3:17022","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"5959_CR3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","volume":"71","author":"S Antoni","year":"2017","unstructured":"Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F (2017) Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 71(1):96\u2013108","journal-title":"Eur Urol"},{"issue":"10061","key":"5959_CR4","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","volume":"388","author":"AM Kamat","year":"2016","unstructured":"Kamat AM, Hahn NM, Efstathiou JA et al (2016) Bladder cancer. Lancet 388(10061):2796\u20132810","journal-title":"Lancet"},{"issue":"5","key":"5959_CR5","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.eururo.2012.02.028","volume":"61","author":"RE Hautmann","year":"2012","unstructured":"Hautmann RE, de Petriconi RC, Pfeiffer C, Volkmer BG (2012) Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients. Eur Urol 61(5):1039\u20131047","journal-title":"Eur Urol"},{"issue":"25","key":"5959_CR6","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1200\/JCO.2010.28.7052","volume":"28","author":"AB Apolo","year":"2010","unstructured":"Apolo AB, Riches J, Sch\u00f6der H et al (2010) Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography in bladder cancer. J Clin Oncol 28(25):3973\u20133978","journal-title":"J Clin Oncol"},{"issue":"6","key":"5959_CR7","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/bju.12109","volume":"112","author":"LS Mertens","year":"2013","unstructured":"Mertens LS, Fioole-Bruining A, Vegt E, Vogel WV, van Rhijn BW, Horenblas S (2013) Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography\/computed tomography (PET\/CT) on management of patients with carcinoma invading bladder muscle. BJU Int 112(6):729\u2013734","journal-title":"BJU Int"},{"issue":"7","key":"5959_CR8","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s12149-012-0614-3","volume":"26","author":"Z Yang","year":"2012","unstructured":"Yang Z, Cheng J, Pan L et al (2012) Is whole-body fluorine-18 fluorodeoxyglucose PET\/CT plus additional pelvic images (oral hydration-voiding-refilling) useful for detecting recurrent bladder cancer? Ann Nucl Med 26(7):571\u2013577","journal-title":"Ann Nucl Med"},{"issue":"3","key":"5959_CR9","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.eururo.2016.06.020","volume":"71","author":"J Alfred Witjes","year":"2017","unstructured":"Alfred Witjes J, Lebret T, Comp\u00e9rat EM et al (2017) Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol 71(3):462\u2013475","journal-title":"Eur Urol"},{"issue":"3","key":"5959_CR10","doi-asserted-by":"publisher","first-page":"e387","DOI":"10.1016\/j.clgc.2016.08.009","volume":"15","author":"R Pichler","year":"2017","unstructured":"Pichler R, De Zordo T, Fritz J et al (2017) Pelvic lymph node staging by combined18F-FDG-PET\/CT imaging in bladder cancer prior to radical cystectomy. Clin Genitourin Cancer 15(3):e387\u2013e395","journal-title":"Clin Genitourin Cancer"},{"issue":"8","key":"5959_CR11","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/iju.12045","volume":"20","author":"M Hitier-Berthault","year":"2013","unstructured":"Hitier-Berthault M, Ansquer C, Branchereau J et al (2013) 18 F-fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: a prospective study. Int J Urol 20(8):788\u2013796","journal-title":"Int J Urol"},{"issue":"3","key":"5959_CR12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/bju.12608","volume":"114","author":"H Goodfellow","year":"2014","unstructured":"Goodfellow H, Viney Z, Hughes P et al (2014) Role of fluorodeoxyglucose positron emission tomography (FDG PET)-computed tomography (CT) in the staging of bladder cancer. BJU Int 114(3):389\u2013395","journal-title":"BJU Int"},{"issue":"12","key":"5959_CR13","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1016\/j.ejso.2014.08.479","volume":"40","author":"M Rouanne","year":"2014","unstructured":"Rouanne M, Girma A, Neuzillet Y et al (2014) Potential impact of 18F-FDG PET\/CT on patients selection for neoadjuvant chemotherapy before radical cystectomy. Eur J Surg Oncol 40(12):1724\u20131730","journal-title":"Eur J Surg Oncol"},{"key":"5959_CR14","doi-asserted-by":"crossref","unstructured":"Jeong IG, Hong S, You D, Hong JH, Ahn H, Kim CS (2015) FDG PET-CT for lymph node staging of bladder cancer: a prospective study of patients with extended pelvic lymphadenectomy. Ann Surg Oncol 22(9):3150\u20133156","DOI":"10.1245\/s10434-015-4369-7"},{"issue":"4","key":"5959_CR15","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.eururo.2009.05.014","volume":"57","author":"G Swinnen","year":"2010","unstructured":"Swinnen G, Maes A, Pottel H et al (2010) FDG-PET\/CT for the preoperative lymph node staging of invasive bladder cancer. Eur Urol 57(4):641\u2013647","journal-title":"Eur Urol"},{"issue":"26","key":"5959_CR16","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1200\/JCO.2008.20.6722","volume":"27","author":"AS Kibel","year":"2009","unstructured":"Kibel AS, Dehdashti F, Katz MD et al (2009) Prospective study of [18F] fluorodeoxyglucose positron emission tomography\/computed tomography for staging of muscle-invasive bladder carcinoma. J Clin Oncol 27(26):4314\u20134320","journal-title":"J Clin Oncol"},{"issue":"2","key":"5959_CR17","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1590\/S1677-5538.IBJU.2014.0579","volume":"42","author":"M Uttam","year":"2016","unstructured":"Uttam M, Pravin N, Anish B, Nandita K, Arup M (2016) Is [F-18]-fluorodeoxyglucose FDG-PET\/CT better than ct alone for the preoperative lymph node staging of muscle invasive bladder cancer? Int Braz J Urol 42(2):234\u2013241","journal-title":"Int Braz J Urol"},{"key":"5959_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12894-015-0080-z","volume":"15","author":"F Aljabery","year":"2015","unstructured":"Aljabery F, Lindblom G, Skoog S et al (2015) PET\/CT versus conventional CT for detection of lymph node metastases in patients with locally advanced bladder cancer. BMC Urol 15:87","journal-title":"BMC Urol"},{"issue":"9","key":"5959_CR19","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s00345-016-1772-z","volume":"34","author":"A Soubra","year":"2016","unstructured":"Soubra A, Hayward D, Dahm P et al (2016) The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis. World J Urol 34(9):1229\u20131237","journal-title":"World J Urol"},{"key":"5959_CR20","doi-asserted-by":"publisher","unstructured":"Vind-Kezunovic S, Bouchelouche K, Ipsen P, H\u00f8yer S, Bell C, Bjerggaard Jensen J (2017) Detection of lymph node metastasis in patients with bladder cancer using maximum standardised uptake value and18F-fluorodeoxyglucose positron emission tomography\/computed tomography: results from a high-volume centre including long-term follow-up. Eur Urol Focus. https:\/\/doi.org\/10.1016\/j.euf.2017.06.005","DOI":"10.1016\/j.euf.2017.06.005"},{"key":"5959_CR21","doi-asserted-by":"crossref","unstructured":"ADASP Committee. The Association of Directors of Anatomic and Surgical Pathology (2001) ADASP recommendations for processing and reporting of lymph node specimens submitted for evaluation of metastatic disease. Mod Pathol 14(6):629\u2013632","DOI":"10.1038\/modpathol.3880362"},{"key":"5959_CR22","unstructured":"Soci\u00e9t\u00e9 Fran\u00e7aise de M\u00e9decine Nucl\u00e9aire et d\u2019Imagerie Mol\u00e9culaire (2018) Recommandations de bonne pratique clinique pour l\u2019utilisation de la TEP en canc\u00e9rologie. Available via https:\/\/www.sfmn.org\/drive\/SFMN\/GUIDES%20DE%20PROCEDURES\/GuidesEtRecommandation_PublicWeb\/RBP%20utilisation%20TEP%20en%20cancerologie%20thesaurus_V1.pdf . Accessed May 2018"},{"issue":"5","key":"5959_CR23","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1007\/s00330-016-4549-2","volume":"27","author":"HT Nguyen","year":"2017","unstructured":"Nguyen HT, Shah ZK, Mortazavi A et al (2017) Non-invasive quantification of tumour heterogeneity in water diffusivity to differentiate malignant from benign tissues of urinary bladder: a phase I study. Eur Radiol 27(5):2146\u20132152","journal-title":"Eur Radiol"},{"issue":"9","key":"5959_CR24","doi-asserted-by":"publisher","first-page":"3752","DOI":"10.1007\/s00330-017-4759-2","volume":"27","author":"M Lee","year":"2017","unstructured":"Lee M, Shin SJ, Oh YT et al (2017) Non-contrast magnetic resonance imaging for bladder cancer: fused high b value diffusion-weighted imaging and T2-weighted imaging helps evaluate depth of invasion. Eur Radiol 27(9):3752\u20133758","journal-title":"Eur Radiol"},{"issue":"9","key":"5959_CR25","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1007\/s00330-017-4758-3","volume":"27","author":"V Panebianco","year":"2017","unstructured":"Panebianco V, De Berardinis E, Barchetti G et al (2017) An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer. Eur Radiol 27(9):3759\u20133766","journal-title":"Eur Radiol"},{"key":"5959_CR26","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.1007\/s00330-016-4308-4","volume":"26","author":"T Derlin","year":"2016","unstructured":"Derlin T, Weiberg D, von Klot C et al (2016) 68Ga-PSMA I&T PET\/CT for assessment of prostate cancer: evaluation of image quality after forced diuresis and delayed imaging. Eur Radiol 26:4345\u20134353","journal-title":"Eur Radiol"},{"key":"5959_CR27","doi-asserted-by":"publisher","unstructured":"Davarpanah NN, Yuno A, Trepel JB, Apolo AB (2017) Immunotherapy: a new treatment paradigm in bladder cancer. Curr Opin Oncol. https:\/\/doi.org\/10.1097\/CCO.0000000000000366","DOI":"10.1097\/CCO.0000000000000366"},{"issue":"3","key":"5959_CR28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.eururo.2017.06.012","volume":"72","author":"M Rijnders","year":"2017","unstructured":"Rijnders M, de Wit R, Boormans JL, Lolkema MPJ, van der Veldt AAM (2017) Systematic review of immune checkpoint inhibition in urological cancers. Eur Urol 72(3):411\u2013423","journal-title":"Eur Urol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-018-5959-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-018-5959-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-018-5959-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T21:01:42Z","timestamp":1721077302000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-018-5959-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,21]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["5959"],"URL":"https:\/\/doi.org\/10.1007\/s00330-018-5959-0","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,21]]},"assertion":[{"value":"5 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Antoine Girard.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all subjects (patients) in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u2022 prospective\u2022 diagnostic study\u2022 performed at one institution","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}